The Biomedical Translation Bridge (BTB) Program is an initiative of the Medical Research Future Fund, providing up to $1 million in matching funding to nurture the translation of new therapies, technologies and medical devices through to the proof of concept stage. The BTB program is operated by MTPConnect in partnership with BioCurate, UniQuest, the Medical Device Partnering Program and the Bridge and BridgeTech programs. BioCurate … Continue reading Adelaide Biomedical Translation Bridge Program Information Session: Round 2 »

The Biomedical Translation Bridge (BTB) Program is an initiative of the Medical Research Future Fund, providing up to $1 million in matching funding to nurture the translation of new therapies, technologies and medical devices through to the proof of concept stage. The BTB program is operated by MTPConnect in partnership with BioCurate, UniQuest, the Medical Device Partnering Program and the Bridge and BridgeTech programs. BioCurate … Continue reading Brisbane Biomedical Translation Bridge Program Information Session: Round 2 »

The Lorne Infection and Immunity Conference brings together scientists, students, health care and industry from multiple disciplines with a shared interest in infection and immunity research. BioCurate CEO Dr C. Glenn Begley will be presenting Thursday 20 February as part of the Infection and immunity in translation afternoon session. For more information, visit the Lorne Infection and Immunity Conference 2020 website.

The Biomedical Translation Bridge (BTB) Program is an initiative of the Medical Research Future Fund, providing up to $1 million in matching funding to nurture the translation of new therapies, technologies and medical devices through to the proof of concept stage. The BTB program is operated by MTPConnect in partnership with BioCurate, UniQuest, the Medical Device Partnering Program and the Bridge and BridgeTech programs. BioCurate … Continue reading Westmead Biomedical Translation Bridge Program Information Session: Round 2 »

Due to the evolving global medical crisis caused by the COVID-19 pandemic and its current escalation in Australia, the Eradicate Cancer organisers have decided to postpone the conference. The conference is currently awaiting clarification on the situation before going any further. Plenty of notification will be given about new dates once settled. This conference brings together the necessary ingredients to create a meaningful immunotherapeutic platform … Continue reading Eradicate Cancer 2020 – Next frontiers in immunotherapy »

In light of the COVID-19 policy statements by the Commonwealth, Victorian and New South Wales Governments, and in order to provide certainty to the presenters, registrants and sponsors, the inaugural Business of Regenerative Medicine Asia Pacific Symposium has been cancelled. CCRM Australia and the New South Wales Stem Cell Network are co-hosting the Business of Regenerative Medicine Asia Pacific symposium from 20th to 21st April … Continue reading Business of Regenerative Medicine Asia Pacific »

AusBiotech + Invest 2020 – Australia’s largest life science conference is back and will be delivered online live 28 – 30 October and on-demand. The world has changed and AusBiotech + Invest 2020 has moved online to ensure maximum flexibility and accessibility. Australia’s biggest week in biotech will feature the event you’ve known and trusted for 35 years, with new opportunities for global delegates and … Continue reading AusBiotech + Invest 2020 »

Bio Connections Australia explores drug development, early phase clinical trials, translational research and expediting Australia’s great science into commercialization. It comes at a critical time for Australia’s medical research sector. The focus of the agenda this year will be on translation and commercialization of homegrown Australian research, improving drug development and clinical trials in Australia as well as the impact of COVID-19 on the landscape. … Continue reading BioConnections Australia »

Bio Connections Australia explores drug development, early phase clinical trials, translational research and expediting Australia’s great science into commercialization. 2020 saw significant disruption to the drug development and clinical trials landscape in Australia and around the world. Australia’s response was remarkable in its ability to respond to the challenges and capture opportunities. How we maintain that momentum and build upon this is an important theme … Continue reading BioConnections Australia 2021 »

Find out how BioCurate can help you translate your research at our Information Session Join us to learn more about BioCurate, BioCurate's evaluation process, selection and funding process, as well as the Proof-of-Concept Fund, ahead of the next round of BioCurate Opportunity Assessment (BOA) applications (open 7 August – close 15 September 2023). The information session will be followed by a panel, and then networking … Continue reading Proof-of-Concept Funding and Development of Therapeutics with BioCurate Information Session at Melbourne Connect »